Akari Therapeutics Plc Stock Price History
AKTX Stock | USD 1.21 0.09 8.04% |
Below is the normalized historical share price chart for Akari Therapeutics PLC extending back to May 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Akari Therapeutics stands at 1.21, as last reported on the 30th of November, with the highest price reaching 1.28 and the lowest price hitting 1.15 during the day.
If you're considering investing in Akari Stock, it is important to understand the factors that can impact its price. Akari Therapeutics PLC secures Sharpe Ratio (or Efficiency) of -0.21, which signifies that the company had a -0.21% return per unit of standard deviation over the last 3 months. Akari Therapeutics PLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Akari Therapeutics' risk adjusted performance of (0.15), and Mean Deviation of 4.64 to double-check the risk estimate we provide.
At this time, Akari Therapeutics' Stock Based Compensation is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 16.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 4.7 M in 2024. . Price Earnings Ratio is likely to drop to -1.6 in 2024. Price Book Value Ratio is likely to rise to -63.35 in 2024. Akari Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of September 2015 | 200 Day MA 2.5482 | 50 Day MA 2.6737 | Beta 0.951 |
Akari |
Sharpe Ratio = -0.2072
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AKTX |
Estimated Market Risk
7.12 actual daily | 63 63% of assets are less volatile |
Expected Return
-1.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Akari Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akari Therapeutics by adding Akari Therapeutics to a well-diversified portfolio.
Price Book 3.0692 | Book Value (0.04) | Enterprise Value 26.5 M | Enterprise Value Ebitda (0.06) | Shares Float 10.5 B |
Akari Therapeutics Stock Price History Chart
There are several ways to analyze Akari Stock price data. The simplest method is using a basic Akari candlestick price chart, which shows Akari Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 11, 2024 | 3.5 |
Lowest Price | November 25, 2024 | 1.03 |
Akari Therapeutics November 30, 2024 Stock Price Synopsis
Various analyses of Akari Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Akari Stock. It can be used to describe the percentage change in the price of Akari Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Akari Stock.Akari Therapeutics Price Action Indicator | 0.04 | |
Akari Therapeutics Price Rate Of Daily Change | 1.08 | |
Akari Therapeutics Accumulation Distribution | 5,950 | |
Akari Therapeutics Price Daily Balance Of Power | 0.69 |
Akari Therapeutics November 30, 2024 Stock Price Analysis
Akari Stock Price History Data
The price series of Akari Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 2.8 with a coefficient of variation of 26.41. The prices are distributed with arithmetic mean of 2.64. The median price for the last 90 days is 2.66. The company had 1:20 stock split on 17th of August 2023.Open | High | Low | Close | Volume | ||
11/29/2024 | 1.20 | 1.28 | 1.15 | 1.21 | 58,586 | |
11/27/2024 | 1.12 | 1.15 | 1.06 | 1.12 | 42,298 | |
11/26/2024 | 1.10 | 1.19 | 0.90 | 1.14 | 157,623 | |
11/25/2024 | 1.30 | 1.31 | 1.03 | 1.03 | 193,505 | |
11/22/2024 | 1.23 | 1.33 | 1.10 | 1.30 | 142,223 | |
11/21/2024 | 1.45 | 1.45 | 1.10 | 1.24 | 178,031 | |
11/20/2024 | 1.68 | 1.68 | 1.46 | 1.47 | 97,567 | |
11/19/2024 | 2.45 | 2.45 | 1.49 | 1.57 | 312,816 | |
11/18/2024 | 2.20 | 2.33 | 2.20 | 2.29 | 19,920 | |
11/15/2024 | 2.17 | 2.17 | 1.77 | 2.08 | 19,448 | |
11/14/2024 | 2.40 | 2.40 | 2.23 | 2.23 | 5,644 | |
11/13/2024 | 2.23 | 2.39 | 2.23 | 2.24 | 5,517 | |
11/12/2024 | 2.28 | 2.30 | 2.25 | 2.30 | 1,958 | |
11/11/2024 | 2.32 | 2.38 | 2.21 | 2.30 | 12,504 | |
11/08/2024 | 2.52 | 2.56 | 2.28 | 2.45 | 20,580 | |
11/07/2024 | 2.28 | 2.43 | 2.28 | 2.43 | 2,076 | |
11/06/2024 | 2.43 | 2.43 | 2.21 | 2.32 | 9,697 | |
11/05/2024 | 2.39 | 2.50 | 2.22 | 2.43 | 39,553 | |
11/04/2024 | 2.91 | 2.91 | 2.20 | 2.43 | 50,984 | |
11/01/2024 | 2.54 | 3.15 | 2.43 | 2.78 | 47,292 | |
10/31/2024 | 2.44 | 2.57 | 2.40 | 2.40 | 4,439 | |
10/30/2024 | 2.58 | 2.58 | 2.32 | 2.41 | 12,123 | |
10/29/2024 | 2.47 | 2.50 | 2.36 | 2.50 | 25,731 | |
10/28/2024 | 2.30 | 2.49 | 2.30 | 2.40 | 2,296 | |
10/25/2024 | 2.26 | 2.50 | 2.25 | 2.36 | 12,499 | |
10/24/2024 | 2.25 | 2.44 | 2.21 | 2.27 | 17,468 | |
10/23/2024 | 2.13 | 2.21 | 2.13 | 2.21 | 1,940 | |
10/22/2024 | 2.23 | 2.25 | 2.10 | 2.13 | 11,160 | |
10/21/2024 | 2.23 | 2.33 | 2.14 | 2.16 | 8,912 | |
10/18/2024 | 2.26 | 2.49 | 2.22 | 2.24 | 8,488 | |
10/17/2024 | 2.44 | 2.49 | 2.20 | 2.21 | 9,335 | |
10/16/2024 | 2.72 | 2.73 | 2.40 | 2.52 | 2,491 | |
10/15/2024 | 2.83 | 2.88 | 2.37 | 2.55 | 14,620 | |
10/14/2024 | 2.65 | 2.87 | 2.51 | 2.66 | 24,130 | |
10/11/2024 | 2.52 | 2.99 | 2.52 | 2.70 | 9,862 | |
10/10/2024 | 2.97 | 2.97 | 2.64 | 2.64 | 22,838 | |
10/09/2024 | 3.13 | 3.13 | 2.80 | 2.95 | 36,970 | |
10/08/2024 | 3.01 | 3.19 | 3.00 | 3.06 | 3,436 | |
10/07/2024 | 2.97 | 3.70 | 2.56 | 3.04 | 14,065 | |
10/04/2024 | 2.99 | 3.01 | 2.76 | 3.01 | 3,431 | |
10/03/2024 | 2.96 | 3.10 | 2.94 | 3.00 | 2,190 | |
10/02/2024 | 3.15 | 3.24 | 2.88 | 2.98 | 5,059 | |
10/01/2024 | 2.78 | 3.00 | 2.78 | 3.00 | 10,689 | |
09/30/2024 | 3.00 | 3.00 | 2.91 | 2.95 | 1,720 | |
09/27/2024 | 3.05 | 3.26 | 2.90 | 2.94 | 11,654 | |
09/26/2024 | 3.16 | 3.85 | 2.67 | 3.05 | 228,222 | |
09/25/2024 | 2.96 | 3.21 | 2.96 | 3.16 | 3,342 | |
09/24/2024 | 3.06 | 3.25 | 2.57 | 2.98 | 15,179 | |
09/23/2024 | 3.20 | 3.20 | 3.20 | 3.20 | 335.00 | |
09/20/2024 | 3.15 | 3.22 | 3.15 | 3.22 | 617.00 | |
09/19/2024 | 3.23 | 3.25 | 3.08 | 3.16 | 3,245 | |
09/18/2024 | 3.40 | 3.40 | 3.14 | 3.14 | 3,293 | |
09/17/2024 | 3.41 | 3.49 | 3.20 | 3.32 | 7,057 | |
09/16/2024 | 3.45 | 3.45 | 3.15 | 3.27 | 11,863 | |
09/13/2024 | 3.50 | 3.58 | 3.18 | 3.26 | 5,726 | |
09/12/2024 | 3.41 | 3.41 | 3.24 | 3.30 | 12,618 | |
09/11/2024 | 3.58 | 3.59 | 3.20 | 3.50 | 9,687 | |
09/10/2024 | 3.38 | 3.64 | 3.38 | 3.42 | 1,727 | |
09/09/2024 | 3.25 | 3.39 | 3.15 | 3.30 | 8,292 | |
09/06/2024 | 3.45 | 3.79 | 3.32 | 3.32 | 6,461 | |
09/05/2024 | 3.82 | 3.82 | 3.25 | 3.25 | 10,043 |
About Akari Therapeutics Stock history
Akari Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Akari is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Akari Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Akari Therapeutics stock prices may prove useful in developing a viable investing in Akari Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 4.9 M | 4.7 M | |
Net Loss | -20 M | -21 M |
Akari Therapeutics Stock Technical Analysis
Akari Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Akari Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Akari Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Akari Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Akari to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.15) | |||
Jensen Alpha | (1.42) | |||
Total Risk Alpha | (2.63) | |||
Treynor Ratio | 4.27 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.